🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This trial studies how well paclitaxel, trastuzumab, and pertuzumab work in...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2020-03-13
Trial ID
NCT04266249
This is an open, prospective and interventional clinical study. Patients wi...
Status
Unknown
Location
The First Affiliated Hospital of Xi'an Jiaotong University
Start Date
2021-01-01
Trial ID
NCT05429684
This is a multicenter, open-label, single-arm, one-stage, phase II study to...
Status
Active Not Recruiting
Location
UMHAT Sveti Ivan Rilski EAD Department of Medical Oncology
Start Date
2021-08-05
Trial ID
NCT04733118
Treatments Being Tested
ADAPT-HER2-IV will address question of optimal neoadjuvant therapy in patie...
Status
Recruiting
Location
Klinikum Mittelbaden, Brustzentrum
Start Date
2024-02-05
Trial ID
NCT05704829
Treatments Being Tested
Doctors leading this study would like to learn about providing cancer treat...
Status
Recruiting
Location
Lagos State University Teaching Hospital
Start Date
2025-03-18
Trial ID
NCT06348134
Treatments Being Tested
Radiation therapy is a crucial part in the comprehensive treatment of breas...
Status
Recruiting
Location
Cancer Hospital ,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Start Date
2024-01-12
Trial ID
NCT06197581
This is a randomized, open label Phase II-III neoadjuvant study comparing t...
Status
Active Not Recruiting
Location
Shengjing Hospital affiliated to China Medical University
Start Date
2022-05-23
Trial ID
NCT05426486
Treatments Being Tested
The study will evaluate the efficacy and safety of trastuzumab deruxtecan (...
Status
Active Not Recruiting
Location
Research Site
Start Date
2021-04-26
Trial ID
NCT04784715
Treatments Being Tested
This is a randomized, double-blind, multicenter trial，parallel control desi...
Status
Completed
Location
Fudan University Cancer Hospital
Start Date
2020-11-23
Trial ID
NCT04629846
Treatments Being Tested
Dynamic observationaL study with PET of 68Ga-HER2-affibody in anti-HER2 tre...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2021-02-18
Trial ID
NCT04769050